192 related articles for article (PubMed ID: 32053771)
1. First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors.
Ruano D; López-Martín JA; Moreno L; Lassaletta Á; Bautista F; Andión M; Hernández C; González-Murillo Á; Melen G; Alemany R; Madero L; García-Castro J; Ramírez M
Mol Ther; 2020 Apr; 28(4):1033-1042. PubMed ID: 32053771
[TBL] [Abstract][Full Text] [Related]
2. Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study.
García-Castro J; Alemany R; Cascalló M; Martínez-Quintanilla J; Arriero Mdel M; Lassaletta A; Madero L; Ramírez M
Cancer Gene Ther; 2010 Jul; 17(7):476-83. PubMed ID: 20168350
[TBL] [Abstract][Full Text] [Related]
3. Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma.
Morales-Molina A; Gambera S; Leo A; García-Castro J
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737338
[TBL] [Abstract][Full Text] [Related]
4. Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells.
Melen GJ; Franco-Luzón L; Ruano D; González-Murillo Á; Alfranca A; Casco F; Lassaletta Á; Alonso M; Madero L; Alemany R; García-Castro J; Ramírez M
Cancer Lett; 2016 Feb; 371(2):161-70. PubMed ID: 26655276
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Antitumor Efficacy of Oncolytic Adenovirus-loaded Menstrual Blood-derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells.
Moreno R; Fajardo CA; Farrera-Sal M; Perisé-Barrios AJ; Morales-Molina A; Al-Zaher AA; García-Castro J; Alemany R
Mol Cancer Ther; 2019 Jan; 18(1):127-138. PubMed ID: 30322950
[TBL] [Abstract][Full Text] [Related]
6. Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice.
Morales-Molina Á; Gambera S; Cejalvo T; Moreno R; Rodríguez-Milla MÁ; Perisé-Barrios AJ; García-Castro J
Cancer Immunol Immunother; 2018 Oct; 67(10):1589-1602. PubMed ID: 30066102
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
Rincón E; Cejalvo T; Kanojia D; Alfranca A; Rodríguez-Milla MÁ; Gil Hoyos RA; Han Y; Zhang L; Alemany R; Lesniak MS; García-Castro J
Oncotarget; 2017 Jul; 8(28):45415-45431. PubMed ID: 28525366
[TBL] [Abstract][Full Text] [Related]
8. AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses.
Rodríguez-Milla MÁ; Morales-Molina A; Perisé-Barrios AJ; Cejalvo T; García-Castro J
Cancer Gene Ther; 2021 Feb; 28(1-2):64-73. PubMed ID: 32457488
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment.
Keshavarz M; Ebrahimzadeh MS; Miri SM; Dianat-Moghadam H; Ghorbanhosseini SS; Mohebbi SR; Keyvani H; Ghaemi A
Virol J; 2020 May; 17(1):64. PubMed ID: 32370750
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma.
Yoon AR; Hong J; Li Y; Shin HC; Lee H; Kim HS; Yun CO
Cancer Res; 2019 Sep; 79(17):4503-4514. PubMed ID: 31289131
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors.
Nokisalmi P; Pesonen S; Escutenaire S; Särkioja M; Raki M; Cerullo V; Laasonen L; Alemany R; Rojas J; Cascallo M; Guse K; Rajecki M; Kangasniemi L; Haavisto E; Karioja-Kallio A; Hannuksela P; Oksanen M; Kanerva A; Joensuu T; Ahtiainen L; Hemminki A
Clin Cancer Res; 2010 Jun; 16(11):3035-43. PubMed ID: 20501623
[TBL] [Abstract][Full Text] [Related]
12. Superselective intracerebral catheterization for administration of oncolytic virotherapy in a case of diffuse intrinsic pontine glioma.
Carceller F; Aleu A; Casasco A; Guimaraens L; López-Pino MA; Madero L; Ramírez M
J Pediatr Hematol Oncol; 2014 Oct; 36(7):e430-2. PubMed ID: 24327128
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of human mesenchymal stromal cells infected with polymer-coated oncolytic adenovirus induces efficient pancreatic tumor homing and infiltration.
Na Y; Nam JP; Hong J; Oh E; Shin HC; Kim HS; Kim SW; Yun CO
J Control Release; 2019 Jul; 305():75-88. PubMed ID: 31071373
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy.
Mahasa KJ; de Pillis L; Ouifki R; Eladdadi A; Maini P; Yoon AR; Yun CO
Sci Rep; 2020 Jan; 10(1):425. PubMed ID: 31949228
[TBL] [Abstract][Full Text] [Related]
15. Menstrual Blood-Derived Stem Cells as Delivery Vehicles for Oncolytic Adenovirus Virotherapy for Colorectal Cancer.
Guo Y; Zhang Z; Xu X; Xu Z; Wang S; Huang D; Li Y; Mou X; Liu F; Xiang C
Stem Cells Dev; 2019 Jul; 28(13):882-896. PubMed ID: 30991894
[TBL] [Abstract][Full Text] [Related]
16. Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient.
Franco-Luzón L; García-Mulero S; Sanz-Pamplona R; Melen G; Ruano D; Lassaletta Á; Madero L; González-Murillo Á; Ramírez M
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32354143
[TBL] [Abstract][Full Text] [Related]
17. Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors.
Hakkarainen T; Särkioja M; Lehenkari P; Miettinen S; Ylikomi T; Suuronen R; Desmond RA; Kanerva A; Hemminki A
Hum Gene Ther; 2007 Jul; 18(7):627-41. PubMed ID: 17604566
[TBL] [Abstract][Full Text] [Related]
18. A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients.
García M; Moreno R; Gil-Martin M; Cascallò M; de Olza MO; Cuadra C; Piulats JM; Navarro V; Domenech M; Alemany R; Salazar R
Hum Gene Ther; 2019 Mar; 30(3):352-364. PubMed ID: 30234393
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.
Parker Kerrigan BC; Shimizu Y; Andreeff M; Lang FF
Cytotherapy; 2017 Apr; 19(4):445-457. PubMed ID: 28233640
[TBL] [Abstract][Full Text] [Related]
20. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial.
Streby KA; Currier MA; Triplet M; Ott K; Dishman DJ; Vaughan MR; Ranalli MA; Setty B; Skeens MA; Whiteside S; Yeager ND; Haworth KB; Simpson K; Conner J; Cripe TP
Mol Ther; 2019 Nov; 27(11):1930-1938. PubMed ID: 31570234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
